EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer

Reio Ueta iD, Hiroo Imai, Ken Saijo iD, Yoshifumi Kawamura, Shuto Kodera, Chikashi Ishioka iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Reio Ueta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Oxaliplatin, Colorectal Neoplasms, Citrobacter freundii, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oxaliplatin, a third‐generation platinum‐based chemotherapeutic agent, is widely used in the treatment of colorectal cancer (CRC). However, some patients do not respond effectively to oxaliplatin, and intrinsic resistance to the drug poses a significant challenge. Recent studies have revealed an association between the gut microbiome and the progression of CRC. We hypothesized that Citrobacter freundii , a component of the gut microbiome, contributes to oxaliplatin resistance by regulating specific gene expression in CRC cells.

Methods

A bacterial culture filtrate from Citrobacter freundii was employed in the experiments. The CRC cell line RKO, following exposure to this filtrate, was analyzed using high‐throughput RNA sequencing. Candidate genes were identified through MTT assays, siRNA knockdown, and overexpression experiments. Apoptosis and reactive oxygen species (ROS) assays were performed to investigate the underlying mechanisms. Finally, a xenograft mouse model was used to evaluate oxaliplatin resistance in vivo.

Results

Exposure to bacterial culture filtrate from Citrobacter freundii induced oxaliplatin resistance in RKO cells with downregulation of the NINJ2 gene as a possible molecular mechanism. Reduced NINJ2 gene expression suppressed oxaliplatin‐induced apoptosis and ROS generation. A tendency toward reduced oxaliplatin efficacy was observed in vivo when NINJ2 gene expression was suppressed.

Conclusion

This study demonstrates that Citrobacter freundii promotes oxaliplatin resistance in CRC through downregulation of NINJ2 gene. NINJ2 gene may serve as a predictive biomarker and therapeutic target to overcome oxaliplatin resistance in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinColorectal NeoplasmsCitrobacter freundiiDrug Resistance, NeoplasmAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorXenograft Model Antitumor AssaysApoptosisGene Expression Regulation, NeoplasticReactive Oxygen SpeciesMice, NudeFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

Citrobacter freundiibacterial culture filtratecolon cancergut microbiomeoxaliplatin

Substanzen

OxaliplatinAntineoplastic AgentsReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Reio Ueta, Ken Saijo, Chikashi Ishioka

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ueta, R., Imai, H., Saijo, K., Kawamura, Y., Kodera, S., & Ishioka, C. (2025). Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70940

Vancouver

Ueta R, Imai H, Saijo K, Kawamura Y, Kodera S, Ishioka C. Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.70940

BibTeX
@article{Ueta2025,
  author = {Ueta, Reio and Imai, Hiroo and Saijo, Ken and Kawamura, Yoshifumi and Kodera, Shuto and Ishioka, Chikashi},
  title = {Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70940}
}
Kostenlos starten →